Skip to content

Public FDA record

Z-2080-2019: POWERPORT CLEARVUE isp, 6F CHRONOFLEX Catheter, Intermediate NAUTILUS DELTA Kit; POWERPORT CLEARVUE isp

Recall record Z-2080-2019 for Bard Peripheral Vascular Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2080-2019
Company in FDA record
Bard Peripheral Vascular Inc
FDA record creation date
Jul 25, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Certain NAUTILUS DELTA Port Kit product code / lot number combinations may be at risk of experiencing a lack of or a loss of the intravascular ECG signal during port placement procedures when used in combination with the NAUTILUS DELTA" TCS.

Source facts

Action
On June 25, 2018 Bard sent recall notifications to all their customers informing them of the following: "This letter is to inform you of a voluntary product recall issued by Bard Peripheral Vascular, Inc. (BPV), a wholly owned subsidiary of Becton, Dickinson and Company. Specific product code / lot number combinations of the NAUTILUS DELTA" Port Kits are affected as outlined in Attachment 3. These product code / lot number combinations cannot be used with the NAUTILUS DELTA" Tip Confirmation System (TCS), product code 9770323. All other product code / lot number combinations not listed in Attachment 3 can continue to be used by your facility as they are safe to use and are not affected by this product recall. Reason for Recall: Per the current Instructions for Use (IFU), the NAUTILUS DELTA" TCS can be used with implantable ports; however, BPV has identified that the NAUTILUS DELTA" Port Kit product code / lot number combinations listed in Attachment 3 may be at risk of experiencing a lack of or a loss of the intravascular ECG signal during port placement procedures when used in combination with the NAUTILUS DELTA" TCS. During port placement procedures, once the guidewire and dilator have been removed and the catheter is inserted into the introducer sheath, the catheter is flushed with saline through the port flushing hub with attached NAUTILUS DELTA" E Electrical Adaptor (provided with the NAUTILUS DELTA" Port Kits). This should cause an intravascular ECG waveform to appear; however, in multiple instances, it has been reported that no intravascular waveform is generated or the intravascular waveform is generated and subsequently lost. Clinical Risk Statement: The loss of or lack of intravascular signal while advancing the port catheter eliminates the devices intended use, which is to provide catheter tip navigation and positioning guidance based on specified ECG signals. This lack of consistent intravascular signal may lead to a prolonged procedure or inabi
Initiated
2018-06-25
Root cause
Device Design
Distribution
US Nationwide Distribution in the states of FL, CO, WI, OH, IL, KS, AZ, WV, CT, PA, AL, MI and VA
Recall number
Z-2080-2019
Recall status
Completed
CDRH record ID
171729
FDA record created
2019-07-25
Recall event number
82513

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗